BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:34th Pharmacovigilance UK &\; EU 2024\n\n30th &\; 31st J anuary 2024\, SHERATON SKYLINE HOTEL LONDON HEATHROW\, London\, UK\n\nVir tue Insight is glad to invite people to attend as a delegate/sponsor for 34th Pharmacovigilance 2024 which is happening on 30th &\; 31st Januar y 2024\, London\, UK.\n\nPlease contact Kavitha at E-mail - kavitha@virtu einsight.co.in \; or call +44 20 3509 3779\n\nDELEGATE REGISTRATION:\ n\nSuper Early (till 23rd Oct 2023)\n\n1 Delegate - £799 + VAT\n\n3 Deleg ates - £ 1598 + VAT\n\nEarly Bird (24th Oct 2023 – 26th Dec 2023)\n\n1 De legate - £999 + VAT\n\n3 Delegates - £ 1998 + VAT\n\nStandard (from 27th Dec 2023)\n\n1 Delegate - £1299 + VAT\n\n3 Delegates - £ 2598 + VAT\n\nSP ONSORS:\n\nWe have sponsorship opportunities available for the event\, wh ich gives you an opportunity to speak/exhibit\, and create brand awarenes s. \; Here you can have a dedicated networking time\, meet the leadin g international vendors and expand your knowledge of the latest business models. Please email to kavitha@virtueinsight.co.in \; for more detai ls.\n\nKEY SPEAKERS:\n\n\nKHAUDEJA BANO\, Vice President\, Combination Pr oduct Quality\, Amgen\nFABIO DE GREGORIO\, Vice President\, Head of Drug Safety Europe\, Shionogi Europe\nSUMIT MUNJAL\, Vice President\, Global P atient Safety Evaluation\, Takeda Pharmaceuticals\nTANUJA HALADY\, Senior Medical Director\, Head of GPS Oncology Group III\, Merck KGaA\nGEORGIA GAVRIILIDOU\, Associate General Counsel (Executive Director)\, Amgen\nJOH N SOLOMON\, Head of Pharmacovigilance - UK &\; Ireland\, Sanofi\nYVONN E NANCIU\, Country Head Pharmacovigilance\, Bayer\nPAV RISHIRAJ\, Directo r\, Head of Pharmacovigilance\, Ipsen\nMIJAL CHAVDA\, Senior Director\, G lobal Head of GxP Inspections &\; GVP Quality\, Kyowa Kirin\nRAJ BHOGA L\, Director\, R&\;D Business Strategy &\; Operations\, Jazz Pharm aceuticals\nVALENTINA MANCINI\, Senior Director Pharmacovigilance\, QPPV\ , Shionogi Europe\nMICHAEL BEAN\, Senior Director\, BioResearch Regulator y Compliance\, Johnson &\; Johnson\nALINA TUDOR\, Senior Director\, Ph armacovigilance\, Kyowa Kirin International\nPETAR GJORGIEV\, Medical Dir ector &\; Safety Risk Lead\, Pfizer\nJUDY BARRETTO\, Global Process Ow ner\, Signal Management Director\, Roche\nEVI MATHIOU\, Legal\, Complianc e &\; Quality Director\, Novo Nordisk\nMARIANA CALZADA MIJANGOS\, CHC Country Safety Head\, Sanofi\nYUUNG YUUNG YAP\, Head Legal Pharma Operati ons\, Vifor Pharma\nDNYANESHWAR SANAP\, EU/UK QPPV\, Head Regional Pharma covigilance\, Glenmark\nJOHN POUSTIE\, EMEA Director Pharmacovigilance an d UK QPPV\, Haleon\nMARIJA BRIEDE\, Head of Pharmacovigilance\, QPPV\, Gr indeks\nDARIUS-JEAN NAMDJOU\, Head of Regulatory Affairs &\; Pharmacov igilance\, Immunic Therapeutics\nFATIMA YOUSEF GHETHAN\, Quality Culture &\; Implementation Manager\, Executive Administration of Quality &\ ; Patient Safety\, Makkah Healthcare Cluster (UAE)\nDANIELA DI COSMO\, Se nior Safety Advisor\, Global Safety\, Ferring Pharmaceuticals\nDIMITRIS Z AMPATIS\, Global Program Safety Lead\, Sandoz\nGAURI UTTURKAR\, Patient S afety Physician\, UCB\nGURPREET SINGH\, Vice President\, Global Head of P harmacovigilance\, Freyr\nKAPIL BHUTADA\, Senior Director\, Inozyme Pharm a\nMARIA BEATRICE PANICO\, Principal Consultant\, Scendea\nALEXANDER ROUS SANOV\, International Partner\, Life Sciences and Privacy\, Arnold &\; Porter\n\nPlus more joining soon\n\nKEY THEMES DISCUSSED:\n\n\nMarket tr ends and the way forward - Future of pharmacovigilance\nPharmacovigilance : What comes next for the industry?\nCurrent Challenges &\; Opportunit ies in Pharmacovigilance - Pragmatic Approaches\nCollaboration among all the parties (industry\, regulators\, patients\, healthcare professionals\ , WHO\, etc\nRethinking relationship between Sponsor\, Site\, CRO &\; Patients – Working together\nImpact of Technology (AI / ML)\nQuality\, Sa fety\, Signal Detection - Traditional and innovative approaches\nOutsourc ing Pharmacovigilance: Benefits of a Specialized Safety Partner\nPharmaco vigilance &\; Risk Management - Current Status &\; Future Needs\nPl an\, develop and implement the PV Audit strategy plan\nMedical devices – Increasing safety perspective\nPrioritising patients in quest to achieve Patient Safety\nRegulatory - EU and UK Regulations &\; Guidelines in P harmacovigilance\nBest practices &\; the way forward\nBe part of a maj or networking opportunity\n\n \;\n\nGet more from the event\, with a broader scope bringing the whole communications value chain together. Enj oy and make the best out of our dedicated networking time\, meet the lead ing international vendors showcasing the products of tomorrow in the co-l ocated exhibition. Expand your knowledge of the latest business models an d strategies in the high-level conference.\n\n \;\n DTEND:20240131T170000 DTSTAMP:20260307T160712Z DTSTART:20240130T093000 LOCATION:Sheraton Skyline Hotel London Heathrow\, Bath Road\, Hayes\, Grea ter London\, UB3 5BP\, SEQUENCE:0 SUMMARY:34th Pharmacovigilance UK &\; EU 2024\n30th &\; 31st January 2024\, SHERATON SKYLINE HOTEL LONDON HEATHROW\, London\, UK\nVirtue Insi ght is glad t... UID:a2bc85c8-7384-4c4a-81c6-e07bbb17aed6 END:VEVENT END:VCALENDAR